16-05-2026 02:00 via cell.com

Reprogramming halophilic life for low-salt biomanufacturing

By reengineering Halomonas bluephagenesis to grow and produce polyhydroxybutyrate under low-salinity, open conditions, Sun et al. transform salinity from a fixed physiological constraint into a bioprocess variable. This study reframes halophilic chassis design for more flexible and sustainable industrial biomanufacturing.
Read more »

Biotechnology news



Prediction Market Betting on Drug Trials and Approvals Sparks Concern About Undermining Research
Chemical actuation expands the design space of living light materials
Mary-Dell Chilton Dies at 87; Helped Create First Genetically Modified Plant
Programmable mycolysins expand the antimicrobial toolkit against mycobacteria
The New Race to Find Treatments for Measles
With Measles Roaring Back, the Search for a Drug is On
Better Sex, Better Hair, Better Sleep: ‘Humanmaxxing’ Is Here
As Ebola Spreads in East Africa, Will China Step Up?
J. Craig Venter (1946—2026)
China’s Rise in Drug Development Looms Over U.S.
Biotechnologies based on the fungal bioluminescence pathway
Blue at the edge
The Rich and Powerful Want to Live Forever
Targeting the gut–joint axis: an oral Spirulina hydrogel as an adjuvant strategy for rheumatoid arthritis therapy
Desktop versie